News
Contributors
WILMINGTON, DEL.—Womble Bond Dickinson took an active role in the annual Delaware Bio Executive Reception, which took place Oct. 24 at Oberod Estates in Wilmington.
The three-hour educational and networking event brought together senior leaders from the biotech, pharmaceutical and life sciences industries, as well as top officials from state and local government. Womble Bond Dickinson was a sponsor of the Delaware Bio Executive Reception, and attorneys Daniel Attaway, Kristen Cramer and Dana Severance represented the firm at the event. Cramer provided brief remarks during the event. Marketing & Client Resources Manager Angela Long provided client development support.
Womble Bond Dickinson is a member of Delaware Bio, in addition to being a sponsor of this event.
Daniel Attaway represents pharmaceutical and biotech patent holders in Abbreviated New Drug Application (“ANDA”) and related patent litigation. He also has represented clients in non-practicing entity (NPE) and trade secrets cases in both state and federal court in Delaware. In addition, Daniel serves as Delaware counsel for out of state clients before the US District Court for the District of Delaware.
Kristen Healey Cramer represents domestic and international clients as lead counsel in patent infringement actions in federal district and appellate courts and in inter partes review proceedings before the PTAB. She also serves as local trial counsel in Delaware and New Jersey. She has litigated patent matters involving pharmaceuticals, medical devices, biotechnology, consumer products and electronics, computer networks, power, and business methods, among other technologies.
Dana Severance is a patent litigator with particular experience in pharmaceutical patent infringement matters, such as Abbreviated New Drug Application (ANDA) disputes. She represents domestic and international clients as lead counsel in patent infringement actions before US district courts.
Above: Dustin Sleesman, associate professor of management at the Alfred Lerner College of Business and Economics at the University of Delaware
Above: Helen Stimson, President & CEO of Delaware BioScience Association (Delaware Bio)
Related sectors
